Showing 3561-3580 of 7110 for: Cochrane Systematic Reviews Back
- Intravenous fluids for reducing the duration of labour in low risk nulliparous women
Cochrane Systematic Reviews, 18-Jun-2013
Several factors may influence the progression of normal labour. It has been postulated that the routine administration of intravenous fluids to keep women adequately hydrated during labour may reduce the period of contraction and relaxation of the uterine
- Intra-venous fluids for the prevention of severe ovarian hyperstimulation syndrome
Cochrane Systematic Reviews, 19-Dec-2010
Ovarian hyperstimulation syndrome (OHSS) is a serious and potentially fatal complication of ovarian stimulation, which affects 1% to 14% of all in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycles. A number of clinical studies wi
- Intravenous immunoglobulin as adjuvant therapy for Wegener's granulomatosis
Cochrane Systematic Reviews, 20-Nov-2012
Wegener's granulomatosis (WG) is a necrotizing small-vessel vasculitis that can affect any organ in the body but mainly affects the upper and lower respiratory tract, the kidneys, joints, skin and eyes. The current mainstay of remission induction therapy
- Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy
Cochrane Systematic Reviews, 20-Dec-2013
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes progressive or relapsing weakness and numbness of the limbs, developing over at least two months. Uncontrolled studies suggest that intravenous immunoglobulin (IVIg) helps. This revie
- Intravenous immunoglobulin for Guillain-Barré syndrome
Cochrane Systematic Reviews, 19-Sep-2014
Guillain-Barré syndrome (GBS) is an acute, paralysing, inflammatory peripheral nerve disease. Intravenous immunoglobulin (IVIg) is beneficial in other autoimmune diseases. This is an update of a review first published in 2001 and previously updated in 200
- Intravenous immunoglobulin for multifocal motor neuropathy
Cochrane Systematic Reviews, 3-Nov-2008
Multifocal motor neuropathy is a rare, probably immune mediated disorder characterised by slowly progressive, asymmetric, distal weakness of one or more limbs with no objective loss of sensation. It may cause prolonged periods of disability. The treatment
- Intravenous immunoglobulin for myasthenia gravis
Cochrane Systematic Reviews, 14-Nov-2012
Myasthenia gravis is an autoimmune disease in which autoantibodies interfere with neuromuscular transmission. As with other autoimmune diseases, people with myasthenia gravis would be expected to benefit from intravenous immunoglobulin (IVIg). This is an
- Intravenous immunoglobulin for presumed viral myocarditis in children and adults
Cochrane Systematic Reviews, 5-May-2015
This is an update of a previous review. Case reports and case series have described dramatic responses to intravenous immunoglobulin (IVIG) in people with presumed viral myocarditis, and its administration has become commonplace.
- Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants
Cochrane Systematic Reviews, 2-Jul-2013
Nosocomial infections continue to be a significant cause of morbidity and mortality among preterm and/or low birth weight (LBW) infants. Preterm infants are deficient in immunoglobulin G (IgG); therefore, administration of intravenous immunoglobulin (IVIG
- Intravenous immunoglobulin for suspected or proven infection in neonates
Cochrane Systematic Reviews, 27-Mar-2015
Neonates are at higher risk of infection due to immuno-incompetence. Maternal transport of immunoglobulins to the fetus mainly occurs after 32 weeks' gestation, and endogenous synthesis begins several months after birth. Administration of intravenous immu
- Intravenous immunoglobulin for the treatment of Kawasaki disease in children
Cochrane Systematic Reviews, 25-Aug-2008
Kawasaki disease is the most common cause of acquired heart disease in children in developed countries. The coronary arteries supplying the heart can be damaged in Kawasaki disease. The principal advantage of timely diagnosis is the potential to prevent t
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
Cochrane Systematic Reviews, 13-Sep-2013
Mortality from sepsis and septic shock remains high. Results of trials on intravenous immunoglobulins (IVIG) as adjunctive therapy for sepsis have been conflicting. This is an update of a Cochrane review that was originally published in 1999 and updated i
- Intravenous immunoglobulins for epilepsy
Cochrane Systematic Reviews, 7-Dec-2010
Epilepsy is a common neurological condition, with an estimated incidence of 50 per 100,000 persons. People with epilepsy may present with various types of immunological abnormalities, such as low serum IgA level, lack of IgG subclass and identification of
- Intravenous immunoglobulins for multiple sclerosis
Cochrane Systematic Reviews, 19-Jan-2010
Animal experiments suggest that intravenous immunoglobulins can reverse some of the disease process of central nervous system demyelination. Subsequently, clinical trials of intravenous immunoglobulins have been conducted in people with multiple sclerosis
- Intravenous in-line filters for preventing morbidity and mortality in neonates
Cochrane Systematic Reviews, 5-Aug-2015
Venous access is an essential part of caring for the sick neonate. However, problems such as contamination of fluids with bacteria, endotoxins and particulates have been associated with intravenous infusion therapy. Intravenous in-line filters claim to be
- Intravenous iron versus oral iron versus no iron with or without erythropoiesis‐ stimulating agents (ESA) for cancer patients with anaemia: a systematic review and network meta‐analysis
Cochrane Systematic Reviews, 20-Jun-2022
Anaemia is common among cancer patients and they may require red blood cell transfusions. Erythropoiesis-stimulating agents (ESAs) and iron might help in reducing the need for red blood cell transfusions. However, it remains unclear whether the combinatio
- Intravenous lidocaine for the treatment of background or procedural burn pain
Cochrane Systematic Reviews, 17-Oct-2014
This is an update of the review on "Lidocaine for pain relief in burn injured patients" first published in Issue 3, 2007, and first updated in 2012. Pain is a major issue for people with many different types of wounds, in particular those people with burn
- Intravenous magnesium for acute myocardial infarction
Cochrane Systematic Reviews, 30-Sep-2008
Mortality and morbidity from acute myocardial infarction (AMI) remain high. Intravenous magnesium started early after the onset of AMI is thought to be a promising adjuvant treatment. Conflicting results from earlier trials and meta-analyses warrant a sys
- Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department
Cochrane Systematic Reviews, 21-May-2014
Asthma is a chronic respiratory condition characterised by airways inflammation, constriction of airway smooth muscle and structural alteration of the airways that is at least partially reversible. Exacerbations of asthma can be life threatening and place
- Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit
Cochrane Systematic Reviews, 22-Jul-2014
Proper sedation for neonates undergoing uncomfortable procedures may reduce stress and avoid complications. Midazolam is a short-acting benzodiazepine that is increasingly used in neonatal intensive care units (NICU). However, its effectiveness as a sedat
